Jorge Corso, MD
Vascular Surgery · Atlanta, GANPI 1235314329
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (39.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Endologix LLC accounts for 63.1% of it on its own, with 26 other manufacturers making up the rest. 2025 is the largest year on record at $7,979, 4.6 times the $1,718 reported in 2019.
Across 127 payments — averaging $145.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$12K
- Abbott$3K
- Bard Peripheral Vascular, Inc.$1K
- W. L. Gore & Associates, Inc.$750
- Medtronic$649
- Silk Road Medical, Inc.$323
- plus $2K from 21 others
Across 4 payments — averaging $5550.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- M.a. Med Alliance S.A.$22K
What the payments were for
- Consulting fees$7,20039%
- Travel & lodging$4,76026%
- Food & beverage$6,50335%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 41 | $11,644 |
| Abbott | 9 | $2,513 |
| Bard Peripheral Vascular, Inc. | 8 | $1,046 |
| W. L. Gore & Associates, Inc. | 11 | $750 |
| Medtronic(2 entities) | 12 | $649 |
| Silk Road Medical, Inc. | 4 | $323 |
| Penumbra, Inc. | 4 | $303 |
| Reflow Medical Inc | 2 | $232 |
| Boston Scientific | 4 | $166 |
| Bolton Medical Inc | 2 | $147 |
| Cook Medical LLC | 3 | $137 |
| Shockwave Medical, Inc | 1 | $105 |
| Johnson & Johnson | 6 | $89 |
| Amgen | 4 | $69 |
| Cordis US CORP. | 2 | $47 |
| Pfizer | 2 | $31 |
| Boehringer Ingelheim | 2 | $29 |
| Cardiva Medical, Inc. | 1 | $24 |
| Baxter Healthcare | 1 | $23 |
| Davol Inc. | 1 | $21 |
| Atricure, Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Sirtex Medical Inc | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| BD | 1 | $16 |
| EKOS Corporation | 1 | $15 |
| Terumo Medical Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENDOCROSS Device$4,606
- Torus Stent Graft System$4,606
- Alto Abdominal Stent Graft System$4,505
- ACCULINK$2,034
- HawkOne$290
- ENROUTE Transcarotid Stent$177
- ENROUTE Transcarotid Neuroprotection System$177
- GORE TAG Thoracic Endoprosthesis$175
- Penumbra Ruby Coil$163
- POD$163
- ESPRIT$151
- TAG Thoracic Endoprosthesis$144
- JETI$130
- IN.PACT Admiral$123
- XACT$123
- Relay Grafts$121
- RUBY Coil$115
- GORE TAG Conformable Thoracic Endoprosthesis$110
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$105
How this compares
$18,463 in reported general payments places this provider in the 80th percentile of 176 vascular surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $22,891 |
| ClopidogrelClopidogrel Bisulfate | 49 | $678 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $31 | $22,89114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 176 vascular surgery providers in Georgia.
Other vascular surgery in Atlanta
- Siddharth PatelAtlanta$303K
- Walaya Methodius-RayfordAtlanta$79K
- Andrew UnzeitigAtlanta$46K
- Yazan DuwayriAtlanta$44K
- Anumeha WhisenhuntAtlanta$33K
- James ChangAtlanta$31K
- Chad AlemanAtlanta$21K
- Olamide AlabiAtlanta$19K
- Peter H DoublerAtlanta$15K
- Eyal Ben-ArieAtlanta$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.